In a shock twist, 23andMe founder and former CEO Anne Wojcicki is about to regain management of the DNA firm’s property, in response to a press launch from 23andMe. In Might, an organization known as Regeneron purchased 23andMe for $256 million in a chapter public sale, however Wojcicki’s nonprofit, TTAM Analysis Institute, was capable of reopen bidding with an “unsolicited provide” of $305 million, The Wall Road Journal studies.
Support Greater and Subscribe to view content
This is premium stuff. Subscribe to read the entire article.
Login if you have purchased
